Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 195

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 195
---
 of such corporation entitled to vote, or (2) the total value of the shares of such corporation is owned, or is considered as owned by applying certain constructive ownership rules, by United States shareholders on any day during the taxable year of such non -U.S. corporation. If the Company Group includes one or more U.S. subsidiaries, certain of the Company’s non -U.S. subsidiaries could be treated as CFCs regardless of whether the Company is treated as a CFC. If the Company or any of its non -U.S. subsidiaries is a CFC, “United States shareholders” under applicable tax rules will be subject to adverse income inclusion and reporting requirements with respect to such CFC. No assurance can be provided that the Company will assist holders in determining whether it or any of its non -U.S. subsidiaries is treated as a CFC or whether any holder is treated as a United States shareholder with respect to any of such CFCs or furnish to any holder information that may be necessary to comply with reporting and tax payment obligations with respect to such CFCs. 76 Risks Related to APx Unless the context otherwise requires, all references in this “Risks Related to APx and the Business Combination” section to “we,” “us” or “our” refer to APx. Our securities have been delisted from Nasdaq. The delisting of our securities may delay, or ultimately prevent, the consummation of the Business Combination. While we continue to work towards its completion, the Business Combination was not consummated as of December 6, 2024, which, as further discussed below, was the deadline Nasdaq had provided us to consummate the Business Combination or face potential delisting from the Nasdaq exchange as a result of non -compliancewith certain of Nasdaq’s continued listing requirements. On September 4, 2024, we received written notice from the Listing Qualifications Department of Nasdaq indicating that since the aggregate market value of our outstanding warrants was less than $1 million, we were no longer in compliance with the Nasdaq continued listing criteria set forth in Listing Rule 5452(b)(C) (the “Rule”), which required us to maintain an aggregate market value of our outstanding warrants of at least $1 million (the “Notice”). We subsequently submitted a plan to regain compliance with the Rule (the “Compliance Plan”). On October 29, 2024, we received written notice from Nasdaq’s staff, stating that the Compliance Plan was not